Parkinson's Disease/Movement Disorders News

A health care innovation company and a clinical-stage biotech company have announced a partnership to advance a novel apomorphine therapeutic in combination with a wearable drug delivery platform to treat Parkinson’s disease.

Novel forms of a rare genetic variant may contribute to the risk for co-occurring Parkinson’s disease and inflammatory bowel disease, according to research presented in Genome Medicine.

DENVER — Cognitive impairment in Parkinson’s is a mitigating factor for presence of blood-based biomarkers during sleep as indicator of disease progression, according to a poster at the American Academy of Neurology annual meeting.

DENVER — Deterioration of memory and executive functions were associated with worsening quality of life for those with Parkinson’s disease over a 3-year period, according to a poster at the American Academy of Neurology annual meeting.

DENVER — Exposure to airborne manganese may be a significant contributing factor to risk of Parkinson’s disease, according to a poster from the American Academy of Neurology annual meeting.

Nearly all study participants believed to have a synucleinopathy had the presence of alpha-synuclein in their skin samples, according to a study presented at the American Academy of Neurology annual meeting.

DENVER — The American Brain Foundation is funding research to find a cure for Lewy body dementia and discover breakthroughs in neuroinflammation, the group’s executive director said at the American Academy of Neurology annual meeting.

DENVER — A phase 3 trial of ulixacaltamide for essential tremor will involve at-home patient participation and a clinical endpoint of activities of daily living, according to a speaker at the American Academy of Neurology annual meeting.

On April 11, which marks World Parkinson’s Night, the patient-led organization PD Avengers will launch Spark the Night, a global initiative dedicated to raising awareness for Parkinson’s disease.

To mark this April as Parkinson’s Awareness Month, the Parkinson’s Foundation has created the #ABCsofPD to provide information about relevant symptoms, statistics and treatments.